XML 40 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Benefit Plans and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Compensation Cost for Stock-Based Compensation Arrangements

The compensation cost that has been included in the Company’s consolidated statements of operations for all stock-based compensation arrangements is detailed as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Cost of sales

 

$

4,961

 

 

$

25,082

 

 

$

2,597

 

Research and development

 

 

27,030

 

 

 

18,741

 

 

 

5,016

 

Sales, general and administrative

 

 

41,286

 

 

 

37,421

 

 

 

32,943

 

Total

 

$

73,277

 

 

$

81,244

 

 

$

40,556

 

Summary of Stock Option Activity

A summary of the Company’s stock option activity under the equity plans and related information is as follows (in thousands, except as indicated and per share data):

 

 

 

Shares

 

 

Weighted
average
exercise
price

 

 

Weighted
average
remaining
contractual
term
(in years)

 

 

Aggregate
intrinsic
value

 

Outstanding at December 31, 2023

 

 

2,468

 

 

$

3.20

 

 

 

 

 

 

 

Exercised

 

 

(283

)

 

 

2.52

 

 

 

 

 

 

 

Forfeited

 

 

(27

)

 

 

14.74

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

2,158

 

 

$

3.15

 

 

 

3.00

 

 

$

13,298

 

Options vested and expected to vest at
   December 31, 2024

 

 

2,158

 

 

$

3.15

 

 

 

3.00

 

 

$

13,298

 

Options exercisable at
   December 31, 2024

 

 

2,155

 

 

$

3.13

 

 

 

2.99

 

 

$

13,296

 

Summary of Information about Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Units Activity

The following table summarizes information about the restricted stock units and performance-based restricted units activity (in thousands, except as indicated and per share data):

 

 

Shares

 

 

Weighted
average
grant
date fair
value

 

 

Weighted
average
remaining
recognition
period
(in years)

 

Unvested at December 31, 2023

 

 

7,713

 

 

$

13.56

 

 

 

 

Awarded

 

 

5,189

 

 

 

12.56

 

 

 

 

Vested

 

 

(4,616

)

 

 

7.10

 

 

 

 

Forfeited

 

 

(860

)

 

 

13.78

 

 

 

 

Unvested at December 31, 2024

 

 

7,426

 

 

$

12.92

 

 

 

1.06

 

Schedule of Assumptions used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP

The Company estimates the fair value of shares issued to employees under the ESPP using the Black-Scholes option-pricing model. The assumptions used to estimate the fair value of stock purchase rights under the ESPP are as follows:

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Risk-free interest rate

 

4.44% - 5.41%

 

 

4.54% - 5.41%

 

 

0.07% - 4.54%

 

Expected dividend yield

 

 

 

 

 

 

 

 

 

Expected term (years)

 

 

0.50

 

 

0.41 - 0.60

 

 

0.50 - 0.60

 

Volatility

 

54.47% - 91.91%

 

 

40.87% - 62.77%

 

 

50.29% - 64.53%

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following (in thousands):

 

 

 

December 31, 2024

 

Stock options outstanding

 

 

2,158

 

Unvested restricted stock units

 

 

7,426

 

Employee stock purchase plan

 

 

714

 

Senior convertible notes

 

 

17,246

 

Warrants outstanding

 

 

9,316

 

Authorized for future grant under the Distributor and
   Development Services plans

 

 

424

 

Authorized for future grant under the Management
   Objective Strategic Incentive Plan

 

 

1

 

Authorized for future grant under the Company
   Equity plans

 

 

4,528

 

 

 

 

41,813